The incidence of retinopathy of prematurity (ROP) continues to rise due to the improved
survival of very low birth weight infants in developed countries. This epidemic is also fueled …

The population of infants at risk for retinopathy of prematurity (ROP) varies by world region;
in countries with well developed neonatal intensive care services, the highest risk infants are …

Importance Children born prematurely who develop retinopathy of prematurity (ROP) often
develop myopia, and those who require laser treatment may develop very high myopia …

METHODS: Data from the Canadian Neonatal Network and the Canadian Neonatal Follow-
Up Network databases were retrospectively reviewed. Infants born at< 29 weeks' in 2010 …

Purpose To determine the relative effectiveness, major complications, and refractive errors
associated with intravitreal bevacizumab (IVB) versus panretinal photocoagulation (PRP) to …

OBJECTIVE: Among extremely preterm infants, we evaluated whether bevacizumab therapy
compared with surgery for retinopathy of prematurity (ROP) is associated with adverse …

Purpose The current study aims to investigate the neurodevelopment of premature infants
after intravitreal injections of bevacizumab (IVB) for the treatment of retinopathy of …

Purpose: To compare the effect and the treatment outcomes of bevacizumab and
ranibizumab in the treatment of Type 1 retinopathy of prematurity (ROP). Methods: This was …

Purpose: To report reactivation rate after bevacizumab treatment for retinopathy of
prematurity (ROP) in eyes with classic ROP (CROP) versus aggressive posterior ROP …

Objective To systematically review the studies exploring the association between
bevacizumab and neurodevelopmental outcomes. Methods Embase, Medline, CINAHL, and …